Alzheimer’s disease: FDA approves lecanemab amid cost and safety concerns
Elisabeth Mahase
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.
Record
- Archive ID
- doi:10.1136/bmj.p73
- Published
- Jan 11, 2023
- Venue
- BMJ
- DOI
- 10.1136/bmj.p73
- PubMed
- 36631154
- Categories
- Alzheimer's disease research and treatments
- Provenance
- openalex